OptiBiotix Health (LSE:OPTI) Cash-to-Debt : No Debt ⁽¹⁾ (As of Jun. 2023)

View and export this data going back to 2011. Start your Free Trial

What is OptiBiotix Health Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. OptiBiotix Health's cash to debt ratio for the quarter that ended in Jun. 2023 was No Debt ⁽¹⁾.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, OptiBiotix Health could pay off its debt using the cash in hand for the quarter that ended in Jun. 2023.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for OptiBiotix Health's Cash-to-Debt or its related term are showing as below:

LSE:OPTI' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.12 Med: No Debt Max: No Debt
Current: No Debt

During the past 12 years, OptiBiotix Health's highest Cash to Debt Ratio was No Debt. The lowest was 1.12. And the median was No Debt.

LSE:OPTI's Cash-to-Debt is ranked better than
99.74% of 1537 companies
in the Biotechnology industry
Industry Median: 6.49 vs LSE:OPTI: No Debt

OptiBiotix Health Cash-to-Debt Historical Data

The historical data trend for OptiBiotix Health's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

OptiBiotix Health Cash-to-Debt Chart

OptiBiotix Health Annual Data

Trend

Jul10

Jul12

Nov14

Nov15

Nov16

Nov17

Nov18

Dec20

Dec21

Dec22

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

1.12

2.45

No Debt

OptiBiotix Health Semi-Annual Data
	Jul12	Jan13	May14	Nov14	May15	Nov15	May16	Nov16	May17	Nov17	May18	Nov18	May19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Cash-to-Debt	Get a 7-Day Free Trial															1.24	2.45	No Debt	No Debt	No Debt

Competitive Comparison of OptiBiotix Health's Cash-to-Debt

For the Biotechnology subindustry, OptiBiotix Health's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OptiBiotix Health's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OptiBiotix Health's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where OptiBiotix Health's Cash-to-Debt falls into.

OptiBiotix Health Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

OptiBiotix Health's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

OptiBiotix Health had no debt ⁽¹⁾.

OptiBiotix Health's Cash to Debt Ratio for the quarter that ended in Jun. 2023 is calculated as:

OptiBiotix Health had no debt ⁽¹⁾.

OptiBiotix Health (LSE:OPTI) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

OptiBiotix Health Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of OptiBiotix Health's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

OptiBiotix Health (LSE:OPTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OptiBiotix Health PLC (LSE:OPTI) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

OPTI.GB:UK OB3:Germany

Address

Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG

Website

https://www.optibiotix.com

OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.